Will a new US-led IP empire in India put access to medicines at risk?
Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with…
Author
GST and its impact on pharma
Dr Milind Antani, Legal & Tax Counseling Worldwide, Nishith Desai Associates and Ashish Sodhani, Member, International Tax…
GST: The road ahead
Pratik Jain, Partner — Tax, KPMG India shares insights on the way forward after GST implementation
Anti-fungal market: In High Gear
With growing awareness and understanding of fungal infections, India's anti fungal market is slated to grow phenomenally in the…
‘We are on track to serve 10,000 customers by mid 2015’
Preventive healthcare might be the buzzword, but a company down South is working towards a paradigm shift in personalised…
‘We are actively exploring the opportunity to address the Indian market’
Gabriel Perera, Director, Product Development and Business Development – Asia, Blackmores, talks about tropical diseases in India…
DoP declares 2015 as ‘Year of Active Pharmaceutical Ingredients’
BDMA in association with DoP will conduct following programmes. The '2015 - The Year of Active Pharmaceutical
Gavi releases figures of children vaccinated in the last 15 years
Half a billion children vaccinated: Gavi
US FDA bans imports from Ipca Labs plant in Madhya Pradesh
The US Food and Drug Administration (FDA) has banned imports from Indian generic drug maker Ipca Laboratories' plant at Ratlam in…
HBL launches cost effective Pentavalent & Hepatitis B vaccines
To roll vaccines for measles, BCG, rabies (Human), Japanese encephalitis and Hib for supplying to National Immunisation programme